recent
introduct
porcin
epidem
diarrhea
viru
pedv
north
american
swine
herd
highlight
need
effect
vaccin
swine
coronavirus
vaccin
transmiss
gastroenter
viru
tgev
avail
produc
around
world
long
time
effect
vaccin
pedv
deltacoronavirus
recent
develop
still
develop
review
exist
vaccin
technolog
swine
coronavirus
highlight
promis
technolog
may
help
control
import
virus
futur
coronavirus
first
describ
subsequ
isol
number
speci
includ
man
mice
swine
chicken
virus
share
common
morpholog
characterist
fring
clubshap
project
nm
long
around
pleomorph
nm
viral
particl
resembl
solar
corona
master
coronavirus
infect
human
variou
anim
speci
caus
respiratori
gastrointestin
neurolog
diseas
well
hepat
promin
exampl
includ
sever
acut
respiratori
syndrom
viru
sarscov
middleeastern
respiratori
syndrom
viru
merscov
felin
infecti
periton
viru
fipv
name
swine
coronavirus
divid
respiratori
prcov
enteropathogen
coronavirus
transmiss
gastroenter
viru
tgev
porcin
epidem
diarrhea
viru
pedv
porcin
deltacoronaviru
pdcov
latter
similar
epidemiolog
clinic
patholog
featur
famili
coronavirida
current
divid
four
genera
alphacoronaviru
betacoronaviru
gammacoronaviru
deltacoronaviru
tgev
pedv
belong
alphacoronaviru
genu
wherea
pdcov
belong
genu
deltacoronavirus
coronavirus
envelop
singlestrand
positivesens
rna
virus
largest
rna
genom
approxim
kb
report
date
genom
rna
includ
untransl
region
utr
cap
polyadenyl
open
read
frame
orf
occupi
twothird
genom
encod
two
replicas
polyprotein
express
protein
requir
ribosom
frameshift
translat
genom
rna
produc
polyprotein
proteolyt
cleav
nonstructur
protein
proteinas
activ
proxim
onethird
genom
encod
four
structur
protein
includ
spike
envelop
e
membran
nucleocapsid
n
protein
betacoronavirus
addit
membran
protein
hemagglutinin
esteras
interspers
gene
gene
encod
accessori
protein
number
gene
vari
differ
coronavirus
instanc
tgev
accessori
gene
pdcov
wherea
pedv
one
fig
viral
rna
genom
packag
n
protein
helic
nucleocapsid
addit
structur
role
n
protein
prolong
sphase
cell
cycl
induc
endoplasm
reticulum
stress
upregul
express
antagon
type
interferon
product
ding
et
al
xu
et
al
protein
form
peplom
virion
surfac
mediat
bind
host
receptor
membran
fusion
divid
domain
coronavirus
protein
process
fragment
cellular
proteas
trypsin
belouzard
et
al
wicht
et
al
protein
major
target
viru
neutral
antibodi
chang
et
al
reguera
et
al
protein
abund
virion
compon
also
contain
conserv
linear
bcell
epitop
zhang
et
al
e
protein
respons
assembl
virion
caus
endoplasm
reticulum
stress
express
upregul
xu
et
al
accessori
gene
dispens
viru
growth
vitro
may
play
import
role
viru
surviv
infect
host
inde
product
tgev
accessori
gene
reduc
express
gene
involv
antivir
defens
immun
system
eg
interferon
respons
inflamm
cruz
et
al
protein
pedv
function
ion
channel
thought
relat
virul
pedv
song
et
al
wang
et
al
one
pedv
nonstructur
protein
shown
type
interferon
suppressor
zhang
et
al
interestingli
pdcov
lack
gene
coronavirus
target
predominantli
type
ii
pneumocyt
prcov
villousand
crypt
enterocyt
intestin
tgev
pedv
pdcov
pedv
also
infect
goblet
cell
small
intestin
jung
saif
addit
infect
alveolar
macrophag
lamina
propria
macrophag
shown
swine
coronavirus
laud
et
al
park
shin
entranc
viru
target
cell
mediat
seri
receptor
ligand
interact
includ
heparin
sulfat
huan
et
al
aminopeptidas
n
apn
chen
et
al
li
et
al
importantli
express
level
aminopeptidas
n
appear
correl
level
infect
least
pedv
higher
express
level
sever
infect
li
et
al
zhang
yoo
result
may
perceiv
piglet
born
lower
apn
level
brush
border
may
resist
pedv
piglet
higher
level
enter
infect
tgev
pedv
character
sever
diarrhea
vomit
dehydr
high
morbid
mortal
especi
piglet
less
two
week
age
contrast
infect
respiratori
coronavirus
caus
mild
transient
diseas
pig
age
often
get
unnot
produc
unless
complic
concurr
infect
prcov
infect
short
last
temporari
phase
cough
respiratori
distress
howev
prcov
becom
signific
problem
coinfect
pathogen
porcin
reproduct
respiratori
syndrom
viru
prrsv
jung
et
al
infect
enterocyt
pedv
result
villou
atrophi
lead
malabsorpt
diarrhea
anorexia
within
h
post
infect
vomit
may
occur
typic
last
longer
day
post
infect
diarrhea
found
within
h
post
infect
depend
dose
viru
age
piglet
diarrhea
typic
last
day
last
longer
result
sever
weight
loss
often
made
normal
product
cycl
viral
shed
highest
day
last
day
week
post
infect
surviv
piglet
start
recov
around
day
post
infect
typic
around
time
prolifer
crypt
epithelium
regener
villi
occur
similarli
tgev
infect
villou
enterocyt
caus
diseas
clinic
indistinguish
pedv
mortal
rate
highest
young
piglet
often
reach
contrast
infect
pdcov
caus
milder
infect
piglet
week
age
diarrhea
vomit
anorexia
found
infect
anim
gener
infect
anim
display
much
milder
sign
compar
infect
pedv
tgev
innat
immun
respons
enter
coronavirus
pig
character
rapid
antivir
respons
intestin
includ
releas
interferon
nuclear
factor
kb
antivir
molecul
chattha
et
al
jung
saif
sang
et
al
pig
produc
three
type
interferon
sang
et
al
type
interferon
includ
well
known
interferon
interferon
b
ifnab
pig
encod
mani
differ
gene
type
ii
interferon
pig
type
iii
interferon
includ
interleukin
kotenko
et
al
park
et
al
prokuninaolsson
et
al
sheppard
et
al
zhang
yoo
function
unknown
pig
especi
type
iii
interferon
use
host
counteract
viral
infect
respons
virus
includ
pedv
tgev
develop
strategi
evad
interfer
interferon
respons
sever
viral
protein
includ
structur
nonstructur
protein
identifi
pedv
tgev
suppress
interferon
respons
excel
review
evas
immun
porcin
coronavirus
pleas
see
zhang
yoo
adapt
immun
respons
swine
enter
coronavirus
base
secretori
antibodi
cytotox
cell
includ
secretori
iga
antibodi
siga
produc
antibodysecret
cell
lamina
propria
mucos
tissu
system
antibodi
igg
igm
found
serum
interstiti
tissu
isotyp
transsud
across
mucos
epithelium
lumen
chattha
et
al
horton
vidarsson
cellular
respons
swine
coronavirus
character
helper
cell
support
product
antibodi
cytotox
cell
target
viru
infect
epitheli
cell
pig
predominantli
cell
found
within
intraepitheli
layer
bonnevil
et
al
major
cell
epitop
locat
spike
nucleoprotein
coronavirus
channappanavar
et
al
saif
sestak
et
al
addit
cell
epitop
found
membran
protein
human
sarscov
yang
et
al
neonat
piglet
main
mechan
protect
mediat
lactogen
immun
lactat
siga
igg
igm
passiv
transfer
piglet
via
colostrum
milk
bohl
saif
saif
bohl
salmon
et
al
colostrum
contain
predominantli
igg
transud
sow
serum
absorb
piglet
within
first
h
life
secretori
iga
predominantli
found
milk
transit
colostrum
milk
around
day
age
langel
et
al
siga
produc
antibodi
secret
cell
mammari
gland
shown
mani
year
ago
bohl
saif
bohl
et
al
cell
migrat
gut
mammari
gland
end
pregnanc
confirm
other
varieti
speci
chemokin
other
found
respons
recruit
antibodi
secret
cell
mammari
gland
bourg
et
al
lazaru
et
al
meuren
et
al
meuren
et
al
wilson
butcher
thu
order
enhanc
level
matern
immun
oral
rout
seem
obviou
choic
vaccin
sow
inde
vaccin
enter
coronavirus
design
induc
lactogen
immun
vaccin
sow
howev
administ
via
system
inject
absenc
effect
vaccin
pedv
mani
produc
current
use
lockdown
barn
combin
feed
back
infecti
live
viru
pregnant
sow
howev
durat
immun
often
extent
year
tabl
depend
type
vaccin
use
live
vaccin
typic
provid
longer
last
immun
even
feedback
immun
start
wane
rel
short
period
time
often
even
less
month
excel
review
role
lactogen
immun
pedv
see
langel
et
al
addit
antibodi
colostrum
also
contain
innat
effector
molecul
defensin
antimicrobi
peptid
interleukin
cytokin
hlavova
et
al
mair
et
al
nechvatalova
et
al
salmon
et
al
level
crossprotect
somewhat
unclear
coronavirus
pedv
goed
et
al
report
old
piglet
born
sow
infect
mild
strain
pedv
seven
month
previous
protect
infect
virul
strain
pedv
goed
et
al
experi
sow
challeng
virul
pedv
viru
day
gestat
oral
rechalleng
piglet
three
day
old
none
sow
display
signific
clinic
symptom
piglet
oral
challeng
ml
mucu
scrape
virul
pedv
mortal
morbid
rate
vari
significantli
amongst
piglet
group
overal
morbid
mortal
reduc
piglet
born
sow
preexpos
pedv
tgev
respons
sever
econom
loss
around
globe
sever
vaccin
technolog
develop
commercialis
administr
sow
import
lactogen
immun
establish
bohl
et
al
saif
bohl
howev
disappear
diseas
mani
part
world
fewer
vaccin
commerci
avail
north
america
europ
tabl
current
commerci
tgev
vaccin
live
attenu
vaccin
given
sow
gestat
order
provid
lactogen
immun
newborn
piglet
vaccin
often
avail
bior
trival
vaccin
combin
rotaviru
pedv
andor
escherichia
coli
experiment
vaccin
includ
novel
dna
vaccin
vector
vaccin
recombin
vaccin
tabl
exampl
porcin
adenoviru
use
deliv
tgev
spike
protein
tuboli
nagi
yuan
et
al
use
swine
pox
viru
express
epitop
spike
protein
yuan
et
al
dna
plasmid
gener
pedv
tgev
develop
dna
vaccin
meng
et
al
recombin
protein
spike
nucleocapsid
extens
evalu
recombin
vaccin
follow
express
bacteria
yeast
plant
mani
assess
potenti
mucos
immun
oral
administr
oral
deliveri
demonstr
first
vaccin
pedv
us
develop
harrisvaccin
tm
iowa
condit
licens
vaccin
initi
call
ipe
vaccin
base
truncat
version
pedv
spike
gene
produc
rna
particl
technolog
platform
base
pvek
replicon
vector
deriv
venezuelan
equin
enceph
viru
technolog
propag
defect
singl
cycl
rna
particl
technolog
believ
target
dendrit
cell
longer
version
spike
gene
codon
optim
use
secondgener
vaccin
call
ipe
plu
commerci
avail
porcin
epidem
diarrhea
vaccin
rna
ped
rna
vaccin
induc
immun
young
pig
two
dose
given
intramuscularli
threeweek
interv
vaccin
wean
pig
challeng
homogen
gut
tissu
clinic
isol
display
significantli
reduc
sever
clinic
sign
diarrhea
reduc
viral
shed
first
h
mogler
et
al
vaccin
efficaci
test
sow
three
vaccin
week
prefarrow
piglet
group
challeng
day
age
tcid
pedvco
averag
litter
mortal
control
group
averag
mortal
vaccin
group
crawford
et
al
similar
result
found
sow
previous
expos
pedv
oral
challeng
piglet
within
first
week
averag
litter
mortal
reduc
control
group
vaccin
group
final
greiner
et
al
evalu
vaccin
sow
previous
expos
pedv
vaccin
induc
higher
titer
protein
colostrum
vaccin
sow
reduc
overal
pig
mortal
greiner
et
al
second
vaccin
pedv
us
develop
zoeti
made
commerci
avail
condit
licens
vaccin
consist
inactiv
whole
viru
formul
adjuv
vaccin
test
pedv
neg
sow
vaccin
twice
week
apart
vaccin
n
adjuv
placebo
n
vaccin
safe
immunogen
induc
neutral
antibodi
whole
viru
spike
protein
vaccin
also
test
field
condit
pedv
posit
commerci
herd
sow
n
vaccin
week
prefarrow
control
sow
n
receiv
placebo
vaccin
result
reduct
prewean
mortal
due
pedv
piglet
born
control
sow
versu
piglet
born
vaccin
sow
vaccin
result
time
higher
neutral
antibodi
titer
compar
control
group
addit
pig
per
sow
surviv
third
vaccin
recent
develop
vaccin
infecti
diseas
organizationintervac
canada
vaccin
base
inactiv
viru
formul
adjuv
administ
seroneg
sow
week
prior
farrow
high
level
neutral
antibodi
pedv
found
colostrum
milk
well
serum
piglet
born
vaccin
sow
piglet
oral
infect
day
life
pfu
pedv
isol
co
found
piglet
n
born
vaccin
sow
surviv
infect
show
significantli
reduc
clinic
symptom
weight
loss
viral
shed
contrast
piglet
unvaccin
sow
display
sever
clinic
symptom
includ
weight
loss
dehydr
piglet
die
within
day
post
infect
result
confirm
two
addit
clinic
trial
larg
field
trial
involv
sow
perform
three
commerci
unit
saskatchewan
canada
assess
vaccin
differ
genet
health
status
manag
system
vaccin
demonstr
complet
safe
use
advers
event
includ
inject
site
reaction
reproduct
complic
observ
vaccin
efficaci
evalu
anim
transport
pregnant
sow
week
farrow
vidointervac
high
contain
facil
follow
oral
challeng
day
age
surviv
significantli
higher
piglet
born
vaccin
sow
control
sow
berub
et
al
assess
durat
immun
current
ongo
addit
affin
tag
pedv
protein
express
system
use
subunit
vaccin
administ
pregnant
sow
vaccin
partial
protect
newborn
piglet
infect
pedv
makadiya
et
al
sinc
earli
pedv
outbreak
report
sever
asian
countri
includ
china
japan
thailand
taiwan
philippin
south
korea
vietnam
octob
largescal
outbreak
sever
pedv
report
china
wang
et
al
late
pedv
outbreak
occur
japan
south
korea
taiwan
phylogenet
analysi
pedv
fulllength
genom
sequenc
reveal
pedv
genet
divid
group
classic
field
epidem
pandem
group
divid
two
subgroup
respect
also
possibl
low
moder
effect
current
pedv
vaccin
due
genet
differ
vaccin
field
epidem
strain
kim
et
al
diseas
control
inactiv
bival
tgev
pedv
vaccin
introduc
china
march
trival
attenu
vaccin
pedv
tgev
porcin
rotaviru
also
approv
vaccin
base
classic
strain
grown
high
titer
green
monkey
kidney
vero
cell
data
publish
efficaci
vaccin
howev
de
arriba
et
al
de
arriba
et
al
oral
inocul
convent
rear
piglet
two
differ
dose
attenu
strain
challeng
virul
pedv
strain
three
week
later
vaccin
pig
partial
protect
challeng
low
doseand
high
doseexpos
pig
shed
viru
challeng
sinc
winter
china
experienc
sever
ped
outbreak
devast
damag
swine
industri
outbreak
explain
reemerg
new
pedv
strain
answer
industri
demand
chines
research
develop
bival
pedv
tgev
attenu
vaccin
contain
pedv
strain
bival
attenu
vaccin
base
strain
inactiv
bival
vaccin
base
strain
also
develop
vaccin
current
clinic
evalu
wang
et
al
japan
pedv
strain
attenu
passag
vero
cell
sato
et
al
subsequ
strain
employ
intramuscular
im
live
attenu
vaccin
v
japan
south
korea
addit
two
south
korean
virul
pedv
strain
attenu
serial
cell
cultur
passag
attenu
strain
use
im
live
kill
vaccin
wherea
use
oral
live
vaccin
oral
vaccin
regist
commercialis
philippin
south
korea
multipl
dose
vaccin
program
im
vaccin
follow
order
livekilledkil
livelivekilledkil
respect
interv
start
farrow
commonli
recommend
pregnant
sow
lee
accord
south
korean
studi
administr
commerci
vaccin
increas
surviv
rate
piglet
challeng
virul
wildtyp
pedv
howev
vaccin
significantli
reduc
morbid
rate
viru
shed
lee
also
song
et
al
song
et
al
report
reduct
mortal
rate
suckl
piglet
born
sow
im
vaccin
pedv
vaccin
despit
nationwid
use
commerci
avail
vaccin
south
korea
experienc
devast
ped
epidem
pedv
strain
respons
recent
sever
ped
epidem
asian
countri
north
america
consid
fact
south
korean
research
baek
et
al
test
inactiv
vaccin
base
serial
cultur
strain
kor
pregnant
sow
immun
im
inactiv
adjuv
vaccin
week
prior
farrow
sixday
old
piglet
challeng
homolog
virul
viru
piglet
born
vaccin
sow
reduc
morbid
mortal
quickli
recov
daili
weight
gain
studi
need
evalu
efficaci
vaccin
old
piglet
field
condit
commerci
avail
vaccin
use
asia
tradit
live
attenu
kill
vaccin
howev
research
work
nextgener
vaccin
pedv
tabl
instanc
hou
et
al
hou
et
al
express
pedv
n
protein
surfac
lactobacillu
oral
intranas
inocul
recombin
l
casei
pregnant
sow
mice
result
high
level
nspecif
serum
igg
mucos
iga
similarli
liu
et
al
liu
et
al
express
n
protein
recombin
l
casei
report
enhanc
mucos
system
immun
respons
oral
immun
mice
meng
et
al
meng
et
al
evalu
immunogen
recombin
dna
plasmid
express
gene
pedv
tgev
mice
result
show
recombin
dna
plasmid
increas
prolifer
lymphocyt
number
lymphocyt
addit
dna
vaccin
induc
high
level
ifng
immun
mice
day
postimmun
recombin
dna
plasmid
bear
fulllength
gene
tgev
pedv
stimul
high
level
virusneutr
antibodi
zhang
et
al
zhang
et
al
also
construct
bival
dna
vaccin
coexpress
gene
tgev
pedv
attenu
salmonella
typhimurium
use
oral
deliveri
vaccin
pig
vaccin
pig
develop
tgev
pedvspecif
cellular
humor
immun
respons
howev
challeng
experi
conduct
studi
also
report
express
recombin
pedv
protein
fragment
plant
bae
et
al
cell
line
oh
et
al
feed
mice
transgen
tobacco
plant
express
protein
fragment
contain
pedv
neutral
epitop
induc
pedvspecif
antibodi
cellmedi
immun
respons
anoth
studi
oh
et
al
oh
et
al
establish
porcin
cell
line
stabli
express
fragment
pedv
spike
protein
pregnant
sow
immun
im
time
purifi
adjuv
protein
week
prior
farrow
sow
develop
pedvspecif
neutral
antibodi
respons
serum
colostrum
one
piglet
select
randomli
farrow
sow
challeng
virul
pedv
piglet
born
vaccin
sow
show
reduc
morbid
mortal
viru
shed
howev
low
number
challeng
piglet
hamper
author
conclus
effici
protect
neonat
piglet
disappear
tgev
around
world
need
tgev
vaccin
drop
last
year
north
america
europ
two
major
intern
anim
health
compani
continu
offer
tgev
vaccin
contrast
mani
part
asia
includ
china
korea
still
deal
tgev
outbreak
differ
type
vaccin
still
avail
introduct
pedv
north
american
herd
howev
revers
pictur
highlight
global
need
effect
vaccin
coronavirus
repres
import
group
anim
pathogen
devast
impact
varieti
speci
industri
reli
biosecur
alon
seem
somewhat
riski
case
emerg
diseas
lead
major
econom
loss
wit
north
america
last
two
year
inde
phylogeni
coronavirus
demonstr
great
deal
divers
antigen
variant
may
lead
limit
crossprotect
infect
differ
strain
thu
import
continu
survey
novel
pedv
variant
may
emerg
local
global
antigen
drift
point
mutat
antigen
shift
recombin
event
effect
prevent
control
pedv
coronavirus
achiev
use
vaccin
ideal
vaccin
prevent
mortal
clinic
diseas
newborn
piglet
age
group
serious
affect
diseas
well
viral
shed
lactogen
immun
key
mechan
protect
effort
enhanc
level
antibodi
milk
formul
adjuv
deliveri
mucos
critic
howev
time
also
essenc
deal
new
strain
tradit
manufactur
vaccin
method
like
viru
isol
inactiv
attenu
timeconsum
therefor
research
nextgener
vaccin
rna
particl
dna
subunit
viralvector
approach
critic
prevent
futur
outbreak
emerg
coronaviru
diseas
